JNJ dividend yield: 3.36%. ARCC dividend yield: 9.06%. Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices. Ares Capital is the largest Business Development Company by assets. It provides financing to middle market companies and pays a generous quarterly dividend plus occasional special dividends. With $21B+ in AUM and diversified exposure across industries, ARCC is the benchmark BDC for income investors.
Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
Ares Capital is the largest Business Development Company by assets. It provides financing to middle market companies and pays a generous quarterly dividend plus occasional special dividends. With $21B+ in AUM and diversified exposure across industries, ARCC is the benchmark BDC for income investors.
Is JNJ or ARCC better for dividend income in 2026?
JNJ currently offers a 3.36% yield (4.96/share/year) while ARCC offers 9.06% (1.92/share/year). ARCC provides higher current income. However, JNJ has grown its dividend faster (5.8% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in JNJ vs ARCC earn per year?
With $10,000 invested today: JNJ pays approximately $336/year. ARCC pays approximately $906/year. With DRIP reinvestment over 10 years, these grow to $828/year (JNJ) and $2,279/year (ARCC).
Does JNJ or ARCC pay monthly dividends?
JNJ pays quarterly dividends. ARCC pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this JNJ vs ARCC comparison by email
Save your analysis + get weekly dividend insights. Free forever.